Biotech leader Denali Therapeutics, Inc. plans to open an office in Utah, adding up to 100 new jobs in the state in the next 10 years. The expansion includes capital expenditures of $40 million.
“Denali Therapeutics’ plans to open manufacturing operations in Salt Lake City is just one example of the migration of companies to our great state,” said Kelvyn Cullimore, president of BioUtah.
“As one of the three fastest-growing life sciences communities in the country since 2012, we continue to see strong interest from therapeutic, medical device, diagnostic and digital health companies. Utah is no longer a secret and is rapidly becoming a significant life sciences hub.”